Afatinib

tumor protein p53 ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33360044 Synergy between vinorelbine and afatinib in the inhibition of non-small cell lung cancer progression by EGFR and p53 signaling pathways. 2021 Feb 2
2 34026634 Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study. 2021 1
3 32101536 Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes. 2020 Feb 3
4 32749686 Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma. 2020 Oct 15 6
5 30289575 Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing. 2018 Dec 1
6 28854272 Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression. 2017 2